Holding(s) in Company

RNS Number : 2071B
Intl. Biotechnology Trust PLC
28 February 2014
 



 

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

2. Reason for the notification (please place an X inside the appropriate bracket/s):

 

An acquisition or disposal of voting rights: (X)

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ()

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ()

 

An event changing the breakdown of voting rights: ()

 

Other (please specify): ()

 

3. Full name of person(s) subject to the notification obligation (iii):

 

AstraZeneca UK Limited

 

4. Full name of shareholder(s) (if different from 3.) (iv):

 

 

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

 

26 FEBRUARY 2014

 

6. Date on which issuer notified:

 

28 FEBRUARY 2014

 

7. Threshold(s) that is/are crossed or reached (vi, vii):

 

Below 3%

 

8. Notified details:

 

A: Voting rights attached to shares (viii, ix)

 

 

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction (vi)



Number of shares


Number of voting Rights (viii)


Ordinary Shares

GB0004559349

8,961,652

8,961,652

 

 

Resulting situation after the triggering transaction (vii)

 

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights

% of voting rights (x)







Direct (xi)


Indirect (xii)


Direct


Indirect

Ordinary Shares

GB0004559349




Below 3%


 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument


Expiration Date (xiii)




Exercise/Conversion Period/ Date (xiv)



Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights




N/A

N/A

N/A

N/A

N/A

 

 

C: Financial Instruments with similar economic effect to Qualify Financial Instruments (xv, xvi)

Resulting situation after the triggering transaction

 

Type of financial instrument

Exercise price



Exercise date xvii

Exercise/Conversion Period xviii


Number of voting rights instrument refers to

% of voting rights xix, xx







Nominal

Delta

N/A

N/A

NA

N/A

N/A

N/A

N/A

 

 

Total (A+B+C)

Number of voting rights


% of voting rights


 

Below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xxi):

 

N/A

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

 

11. Number of voting rights proxy holder will cease to hold:

 

N/A

 

12. Date on which proxy holder will cease to hold voting rights:

 

N/A

 

13. Additional information:

 

N/A

 

14. Contact name:

 

Martin Bennett

 

15. Contact telephone number:

 

020 7604 8157

                         

Date: 28 FEBRUARY 2014


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUWRRRSSAUUAR
UK 100

Latest directors dealings